The DOI matches its Crossref record; 52 of the 60 references it cites were found in a registry or an index.
Brca1 Controls Homology-Directed DNA Repair
Open accessAbstract
Germline mutations in BRCA1 confer a high risk of breast and ovarian tumors. The role of BRCA1 in tumor suppression is not yet understood, but both transcription and repair functions have been ascribed. Evidence that BRCA1 is involved in DNA repair stems from its association with RAD51, a homolog of the yeast protein involved in the repair of DNA double-strand breaks (DSBs) by homologous recombination. We report here that Brca1-deficient mouse embryonic stem cells have impaired repair of chromosomal DSBs by homologous recombination. The relative frequencies of homologous and nonhomologous DNA integration and DSB repair were also altered. The results demonstrate a caretaker role for BRCA1 in preserving genomic integrity by promoting homologous recombination and limiting mutagenic nonhomologous repair processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tumor suppressor complex BRCA1-BARD1 functions in DNA double-strand break repair by homologous recombination.”
From BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing (2017) · cites this paper as [18]
Citations
Cites
3 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
Self-citationRetractedCressman, V. L., Backlund, D. C., Avrutskaya, A. V., Leadon, S. A., Godfrey, V., & Koller, B. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7061 · Cited by 108
Self-citationRetractedLeadon, S. A., & Avrutskaya, A. V. (1997) · PubMed · Cited by 78
RetractedThe double-strand-break repair model for recombination
Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J., & Stahl, F. W. (1983) · Cell · doi:10.1016/0092-8674(83)90331-8 · Cited by 2,437
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
XRCC3 promotes homology-directed repair of DNA damage in mammalian cellsPreprint
Pierce, A. J., Johnson, R. D., Thompson, L. H., & Jasin, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2633 · Cited by 1,384
Self-citationKinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
The Genetic Basis of Human Cancer
Vogelstein, B., & Kinzler, K. W. (1997) · Cited by 1,120
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,087
Xu, X., Ohler, Z. W., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., & Deng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819
Cited by
Sorted by citations
Items 401–500 of 999
Weighted Frequent Gene Co-expression Network Mining to Identify Genes Involved in Genome Stability
Zhang, J., Lü, K., Xiang, Y., Islam, M. M., Kotian, S., Kais, Z., Lee, C., Arora, M., Liu, H.-W., Parvin, J. D., et al. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002656 · Cited by 76
A role for Brca1 in chromosome end maintenance
McPherson, J. P., Hande, M. P., Poonepalli, A., Lemmers, B., Matysiak‐Zablocki, E., Migon, E., Shehabeldin, A., Porras, A., Karásková, J., Vukovic, B., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl002 · Cited by 79
Vriend, L. E. M., Prakash, R., Chen, C.-C., Vanoli, F., Cavallo, F., Zhang, Y., Jasin, M., & Krawczyk, P. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw179 · Cited by 77
Self-citationRole of BRCAgene dysfunction in breast and ovarian cancer predisposition
Scully, R. (2000) · Breast Cancer Research · doi:10.1186/bcr76 · Cited by 78
Hoskins, P. J., & Gotlieb, W. H. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21408 · Cited by 77
Wilson, R. H., Evans, T. J., Middleton, M. R., Molife, L. R., Spicer, J. F., Dieras, V. C., Roxburgh, P., Giordano, H., Jaw‐Tsai, S., Goble, S. M., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.36 · Cited by 78
Homologous Recombination Assay for Interstrand Cross-Link Repair
Nakanishi, K., Cavallo, F., Brunet, E., & Jasin, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-129-1_16 · Cited by 76
Self-citationChi, P., Kwon, Y., Seong, C., Epshtein, A., Lam, I., Sung, P., & Klein, H. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602983200 · Cited by 77
Mediators of Homologous DNA PairingPreprint
Zelensky, A. N., Kanaar, R., & Wyman, C. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016451 · Cited by 81
The emerging role of Polycomb repressors in the response to DNA damage
Vissers, J. H. A., van Lohuizen, M., & Citterio, E. (2012) · Journal of Cell Science · doi:10.1242/jcs.107375 · Cited by 81
Suppression of retroviral infection by the RAD52 DNA repair protein
Lau, A., Kanaar, R., Jackson, S. P., & O’Connor, M. J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600348 · Cited by 76
Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?
Turner, N. C., & Tutt, A. N. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3332 · Cited by 76
Homologous Recombination and Its Role in Carcinogenesis
Bishop, A. J. R., & Schiestl, R. H. (2002) · BioMed Research International · doi:10.1155/s1110724302204052 · Cited by 77
RNF20–RNF40: A ubiquitin‐driven link between gene expression and the DNA damage response
Shiloh, Y., Shema, E., Moyal, L., & Oren, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.034 · Cited by 77
Homologous recombination as a mechanism of carcinogenesis
Bishop, A. J. R., & Schiestl, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00018-x · Cited by 76
LncRNAs in DNA damage response and repair in cancer cells
Su, M., Wang, H., Wang, W., Wang, Y., Ouyang, L., Chen, P., Xia, L., Cao, D., & Liao, Q. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy022 · Cited by 72
Identification of DBC1 as a transcriptional repressor for BRCA1
Hiraike, H., Wada‐Hiraike, O., Nakagawa, S., Koyama, S., Miyamoto, Y., Sone, K., Tanikawa, M., Tsuruga, T., Nagasaka, K., Matsumoto, Y., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605577 · Cited by 74
BRCA1 and CtIP suppress long-tract gene conversion between sister chromatids
Chandramouly, G., Kwok, A., Huang, B., Willis, N. A., Xie, A., & Scully, R. (2013) · Nature Communications · doi:10.1038/ncomms3404 · Cited by 70
Ubiquitin C-Terminal Hydrolase L1 in Tumorigenesis
Hurst-Kennedy, J., Chin, L., & Li, L. (2012) · Biochemistry Research International · doi:10.1155/2012/123706 · Cited by 71
Severson, T., Wolf, D. M., Yau, C. S. F., Peeters, J. K., Wehkam, D., Schouten, P. C., Chin, S., Majewski, I. J., Michaut, M., Bosma, A. R., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0861-2 · Cited by 77
The role of DNA damage response proteins at telomeres—an “integrative” model
Slijepčević, P. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.038 · Cited by 73
Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors
Cavallo, F., Feldman, D. R., & Barchi, M. (2013) · The International Journal of Developmental Biology · doi:10.1387/ijdb.130135mb · Cited by 72
Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
Chang, S., Biswas, K., Martin, B. K., Stauffer, S., & Sharan, S. K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39836 · Cited by 72
Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo
Wen, Y., Gu, K., Yu, Z., Yuan, D., He, M., Ma, N., Lai, S., Zhao, J., Ren, Z., Zhang, X., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.024 · Cited by 72
Regulation of the Fanconi anemia pathway by monoubiquitination
Gregory, R. C., Taniguchi, T., & D’Andrea, A. D. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00102-5 · Cited by 72
Chen, Y., Zhang, H., Xu, Z., Tang, H., Geng, A., Cai, B., Su, T., Shi, J., Jiang, C., Tian, X., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz592 · Cited by 75
Genome maintenance and transcription integrity in aging and disease
Wolters, S., & Schumacher, B. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00019 · Cited by 73
Akhmedov, A. T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.16.3022 · Cited by 71
Association between DNA Damage Response and Repair Genes and Risk of Invasive Serous Ovarian Cancer
Schildkraut, J. M., Iversen, E. S., Wilson, M. A., Clyde, M. A., Moorman, P. G., Weber, R. P., Whitaker, R. S., Bentley, R. C., Marks, J. R., & Berchuck, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010061 · Cited by 70
Skin cancer risk inBRCA1/2mutation carriers
Gumaste, P. V., Penn, L. A., Cymerman, R. M., Kirchhoff, T., Polsky, D., & McLellan, B. N. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13626 · Cited by 69
Xiao, M., Cai, J., Cai, L., Jia, J., Xie, L., Zhu, Y., Huang, B., Jin, D., & Wang, Z. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0321-8 · Cited by 69
DNA polymerase stalling, sister chromatid recombination and the BRCA genes
Scully, R., Puget, N., & Vlasáková, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203971 · Cited by 68
Caponio, V. C. A., Troiano, G., Adipietro, I., Zhurakivska, K., Arena, C., Mangieri, D., Mascitti, M., Cirillo, N., & Muzio, L. L. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0984-6 · Cited by 68
Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers
Baeyens, A., Thierens, H., Claes, K., Poppe, B. G., Ridder, L. D., & Vral, A. (2004) · International Journal of Radiation Biology · doi:10.1080/09553000400017937 · Cited by 68
The secret life of Bcl-2: Apoptosis-independent inhibition of DNA repair by Bcl-2 family members
Laulier, C., & López, B. S. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.05.002 · Cited by 70
BRCA1 in the DNA damage response and at telomeres
Rosen, E. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00085 · Cited by 68
Severson, T., Peeters, J. K., Majewski, I. J., Michaut, M., Bosma, A. R., Schouten, P. C., Chin, S., Pereira, B., Goldgraben, M. A., Bismeijer, T., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.011 · Cited by 67
A Novel Human Rad54 Homologue, Rad54B, Associates with Rad51
Tanaka, K., Hiramoto, T., Fukuda, T., & Miyagawa, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910306199 · Cited by 67
Oliveira, D. V. N. P., Kato, A., Nakamura, K., Ikura, T., Okada, M., Kobayashi, J., Yanagihara, H., Saito, Y., Tauchi, H., & Komatsu, K. (2013) · Journal of Cell Science · doi:10.1242/jcs.135855 · Cited by 73
Cancer, DNA Repair Mechanisms, and Resistance to Chemotherapy
Fojo, T. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.19.1434 · Cited by 67
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
Jacquemont, C. F., Simon, J. A., D’Andrea, A. D., & Taniguchi, T. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-26 · Cited by 69
Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network
Greenberg, R. A. (2008) · Chromosoma · doi:10.1007/s00412-008-0154-8 · Cited by 69
Komen, S. V., Petukhova, G. D., Sigurðsson, S., & Sung, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205864200 · Cited by 65
van Veelen, L. R., Essers, J., van de Rakt, M. W. M. M., Odijk, H., Pastink, A., Zdzienicka, M. Z., Paulusma, C. C., & Kanaar, R. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.01.020 · Cited by 64
Role of homologous recombination in DNA interstrand crosslink repair
Hinz, J. M. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20577 · Cited by 68
BRCA1 Physically and Functionally Interacts with ATF1
Houvras, Y. J., Benezra, M., Zhang, H., Manfredi, J. J., Weber, B. L., & Licht, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002539200 · Cited by 66
The DNA double-strand break response pathway: becoming more BRCAish than ever
Ting, N. S. Y., & Lee, W. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.026 · Cited by 67
BRCA1-associated structural variations are a consequence of polymerase theta-mediated end-joining
Kamp, J. A., van Schendel, R., Dilweg, I. W., & Tijsterman, M. (2020) · Nature Communications · doi:10.1038/s41467-020-17455-3 · Cited by 65
BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis
Krais, J. J., & Johnson, N. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1830 · Cited by 66
The role of BRCA1 in non-homologous end-joining
Bau, D., Mau, Y.-C., & Shen, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.08.003 · Cited by 65
Breast Cancer Genes and DNA Repair
Venkitaraman, A. R. (1999) · Science · doi:10.1126/science.286.5442.1100 · Cited by 65
Collaboration of Brca1 and Chk2 in tumorigenesisPreprint
McPherson, J. P., Lemmers, B., Hirao, A., Hakem, A., Abraham, J., Migon, E., Matysiak‐Zablocki, E., Tamblyn, L., Sanchez-Sweatman, O. H., Khokha, R., et al. (2004) · Genes & Development · doi:10.1101/gad.1192704 · Cited by 67
DNA repair mechanisms protect our genome from carcinogenesis
Moraes, M. C. S. (2012) · Frontiers in Bioscience · doi:10.2741/3992 · Cited by 64
DHX9-dependent recruitment of BRCA1 to RNA promotes DNA end resection in homologous recombination
Chakraborty, P., & Hiom, K. J. (2021) · Nature Communications · doi:10.1038/s41467-021-24341-z · Cited by 67
The Biphasic Effect of Flavonoids on Oxidative Stress and Cell Proliferation in Breast Cancer Cells
Xi, X., Wang, J., Qin, Y., You, Y., Huang, W., & Zhan, J. (2022) · Antioxidants · doi:10.3390/antiox11040622 · Cited by 64
Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53
Süße, S., Janz, C., Janus, F., Deppert, W., & Wiesmüller, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203809 · Cited by 64
Nikkilä, J., Coleman, K. A., Morrissey, D., Pylkäs, K., Erkko, H., Messick, T. E., Karppinen, S.-M., Amelina, A., Winqvist, R., & Greenberg, R. A. (2009) · Oncogene · doi:10.1038/onc.2009.33 · Cited by 63
BRCA Gene Structure and Function in Tumor Suppression
Murphy, C. G., & Moynahan, M. E. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181cf0204 · Cited by 63
Self-citationCai, M., Zhang, H., Hou, L., Gao, W., Song, Y., Cui, X., Li, C., Guan, R., Ma, J., Wang, X., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31781 · Cited by 62
P5 eHealth: An Agenda for the Health Technologies of the Future
Pravettoni, G., & Triberti, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-27994-3 · Cited by 63
The ?portrait? of hereditary breast cancer
Lacroix, M., & Leclercq, G. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2172-4 · Cited by 62
BRCA1 Regulates the Interferon γ-mediated Apoptotic Response
Andrews, H. N., Mullan, P. B., McWilliams, S., Šebelová, Š., Quinn, J. E., Gilmore, P. M., McCabe, N., Pace, A. J., Koller, B. H., Johnston, P. G., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201316200 · Cited by 62
Self-citationTP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis
Olivier, M., & Hainaut, P. L. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0390 · Cited by 62
BRCA1 DNA-Binding Activity Is Stimulated by BARD1
Simons, A. M., Horwitz, A. A., Starita, L. M., Griffin, K., Williams, R. S., Glover, J. N. M., & Parvin, J. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3296 · Cited by 63
Targeting abnormal DNA double strand break repair in cancer
Rassool, F. V., & Tomkinson, A. E. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0493-5 · Cited by 62
XIA, Q., Cai, Y., Peng, R., Wu, G., Shi, Y., & Jiang, W. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2240 · Cited by 62
Independence of R/M/N Focus Formation and the Presence of Intact BRCA1
Wu, X. (2000) · Science · doi:10.1126/science.289.5476.11a · Cited by 61
Targeting the FANCJ–BRCA1 interaction promotes a switch from recombination to polη-dependent bypass
Xie, J., Litman, R., Wang, S., Peng, M., Guillemette, S., Rooney, T., & Cantor, S. B. (2010) · Oncogene · doi:10.1038/onc.2010.18 · Cited by 60
PRMT2 and RORγ Expression Are Associated With Breast Cancer Survival Outcomes
Oh, T. G., Bailey, P. J., Dray, E. V., Smith, A. G., Goode, J. M., Eriksson, N. A., Funder, J. W., Fuller, P. J., Simpson, E. R., Tilley, W. D., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1403 · Cited by 61
Tomita, M. (2010) · Journal of Radiation Research · doi:10.1269/jrr.10039 · Cited by 61
Tumor formation in Brca1 conditional mutant mice
Deng, C. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10069 · Cited by 60
Xie, A., Odate, S., Chandramouly, G., & Scully, R. A. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12884 · Cited by 59
Kitao, H., & Yuan, Z.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208151200 · Cited by 58
Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?
Klotz, D. M., & Wimberger, P. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4529-z · Cited by 59
Reiss, K. A., Yu, S., Judy, R., Symecko, H., Nathanson, K. L., & Domchek, S. M. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00152 · Cited by 61
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
Wang, Y., Bernhardy, A. J., Nacson, J., Krais, J. J., Tan, Y., Nicolas, É., Radke, M. R., Handorf, E., Llop‐Guevara, A., Balmañà, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13530-6 · Cited by 60
Hohenstein, P., Kielman, M. F., Breukel, C., Bennett, L. M., Wiseman, R. W., Krimpenfort, P., Cornelisse, C. J., van Ommen, G. B., Devilee, P., & Fodde, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204363 · Cited by 58
Dual role of CDKs in DNA repair: To be, or not to be
Yata, K., & Esashi, F. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.002 · Cited by 62
Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis
Yeung, B. H. Y., Kwan, B. W. Y., He, Q., Lee, A. S., Liu, J., & Wong, A. S. T. (2008) · Oncogene · doi:10.1038/onc.2008.290 · Cited by 58
Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression
Chen, X., Wang, J., Fu, Z., Zhu, B., Wang, J., Guan, S., & Hua, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-16436-9 · Cited by 58
Karin, B. R., Gamble, T., & Jackman, T. R. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz263 · Cited by 61
BRCA1 Mutational Complementation Induces Synthetic Viability
Nacson, J., Marcantonio, D. D., Wang, Y., Bernhardy, A. J., Clausen, E., Hua, X., Cai, K. Q., Martı́nez, E., Feng, W., Callén, E., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.006 · Cited by 53
Association of p53 and MSH2 with recombinative repair complexes during S phase
Zink, D., Mayr, C., Janz, C., & Wiesmüller, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205614 · Cited by 56
Jiang, G., Plo, I., Wang, T., Rahman, M. A., Cho, J. H., Yang, E. S.-H., López, B. S., & Xia, F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.412650 · Cited by 57
Emerging Role of AP-1 Transcription Factor JunB in Angiogenesis and Vascular Development
Yoshitomi, Y., Ikeda, T., Saito-Takatsuji, H., & Yonekura, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062804 · Cited by 56
Functional differences among BRCA1 missense mutations in the control of centrosome duplication
Kais, Z., Chiba, N., Ishioka, C., & Parvin, J. D. (2011) · Oncogene · doi:10.1038/onc.2011.271 · Cited by 57
BRCA1 and Its Network of Interacting Partners
Christou, C. M., & Kyriacou, K. C. (2013) · Biology · doi:10.3390/biology2010040 · Cited by 58
Cullinane, C. M., Creavin, B., O’Connell, E., Kelly, L., O’Sullivan, M. J., Corrigan, M. A., & Redmond, H. P. (2020) · British journal of surgery · doi:10.1002/bjs.11603 · Cited by 57
Yung, S., Tilgner, K., Ledran, M. H., Habibollah, S., Neganova, I. E., Singhapol, C., Saretzki, G. C., Stojković, M., Armstrong, L., Przyborski, S. A., et al. (2012) · Stem Cells · doi:10.1002/stem.1308 · Cited by 56
Reyngold, M., Nandula, S. V., Modi, A. P., Wang, S., Jasin, M., Murty, V. V. V. S., Ludwig, T., & Baer, R. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705198200 · Cited by 56
Self-citationThe DNA-damage response: new molecular insights and new approaches to cancer therapy
Jackson, S. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370483 · Cited by 59
BRCA1 and p53: compensatory roles in DNA repair
Hartman, A., & Ford, J. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0477-0 · Cited by 62
Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48
Velimezi, G., Robinson-Garcia, L., Muñoz‐Martínez, F., Wiegant, W. W., da Silva, J. F., Owusu, M., Moder, M., Wiedner, M., Rosenthal, S. B., Fisch, K. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04649-z · Cited by 58
PARP Inhibitors in Breast and Ovarian Cancer
Wang, S. S. Y., Jie, Y. E., Cheng, S. W., Ling, G. L., & Heong, V. Y. M. (2023) · Cancers · doi:10.3390/cancers15082357 · Cited by 60
BRCA1 Mutation: A Predictive Marker for Radiation Therapy?
Kan, C. E., & Zhang, J. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.05.037 · Cited by 54
KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair
Lin, Y.-H., Yuan, J., Pei, H., Liu, T., Ann, D. K., & Lou, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123935 · Cited by 56
Functional assays for BRCA1 and BRCA2
Carvalho, M. A., Couch, F. J., & Monteiro, Á. N. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.002 · Cited by 58
Hollis, R. L., Churchman, M., & Gourley, C. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s102569 · Cited by 58
The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.
Turner, B. C., Ottey, M., Zimonjic, D. B., Potoczek, M., Hauck, W. W., Pequignot, E. C., Keck-Waggoner, C. L., Sevignani, C., Aldaz, C. M., McCue, P. A., et al. (2002) · PubMed · Cited by 55
Cell Cycle Checkpoint Control Mechanisms That Can Be Disrupted in Cancer
Dash, B. C., & El‐Deiry, W. S. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:099 · Cited by 55
Metadata
- Authors
- Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Jasin, Maria
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 1999-10
- Volume
- 4
- Issue
- 4
- Pages
- 511-518
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2059365987
- Cited by
- 1,245
- References
- 60
- Citations by year
- 2026: 27 · 2025: 18 · 2024: 22 · 2023: 35 · 2022: 21 · 2021: 42 · 2020: 47 · 2019: 48 · 2018: 53 · 2017: 47 · 2016: 47 · 2015: 45 · 2014: 55 · 2013: 58 · 2012: 47
- FWCI
- 22.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- National Cancer Institute (1P50CA68425, P50CA068425)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, homologous recombination, homology-directed repair, DNA double-strand break repair, RAD51, non-homologous end joining, genome stability, tumor suppression, mouse embryonic stem cells, germline mutations, breast and ovarian cancer
- MeSH terms
- Animals, Arabinofuranosyluracil, Cell Line, Chromosomes, DNA Damage, DNA Repair, DNA-Binding Proteins, Mutation, Proto-Oncogene Proteins, Recombination, Genetic, Stem Cells, Thymidine Kinase, Transfection, Retinoblastoma Protein, Mice, Knockout, Gene Targeting, BRCA1 Protein, Rad51 Recombinase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review